Cytoplasmic RAP1 mediates cisplatin resistance of non-small cell lung cancer
Lu Xiao(State Key Laboratory of Respiratory Disease), Jinbao Liu(State Key Laboratory of Respiratory Disease)
Cited by 97
Related Papers
Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth
|Oncotarget|2014|170
Proteasome-associated deubiquitinase ubiquitin-specific protease 14 regulates prostate cancer proliferation by deubiquitinating and stabilizing androgen receptor
|Cell Death and Disease|2017|118
USP10 modulates the SKP2/Bcr-Abl axis via stabilizing SKP2 in chronic myeloid leukemia
|Cell Discovery|2019|97